Fáilte chuig an Institiúid um Leigheas Athghiniúnach
Welcome to the Regenerative Medicine Institute (REMEDI®)

DIRECTOR BECOMES EDITOR-IN-CHIEF OF STEM CELL RESEARCH & THERAPY JOURNAL

March 16th 2010

Professor Tim O'Brien recently became Co-Editor-in-Chief of the on-line, open access journal Stem Cell Research & Therapy. Additionally, O'Brien joined the Editorial Board of Human Gene Therapy.

The on-line, open access journal Stem Cell Research & Therapy  is the major forum for translational research into stem cell therapies. An international peer-reviewed journal, it publishes open access research articles of outstanding quality. Stem Cell Research & Therapy has a special emphasis on basic, translational, and clinical research into stem cell therapeutics, including animal models, and clinical trials.  Additionally, O'Brien joined the Editorial Board of Human Gene Therapy.

Director of REMEDI, Professor O'Brien comments, "Stem cells have enormous potential for alleviating suffering for many diseases which currently have no effective therapy. The field has progressed to the clinic and it is important that this pathway is underpinned by excellent science and rigorous standards of clinical research. The journal provides an important avenue of publication in translational aspects of stem cell therapy spanning preclinical studies, clinical research and commercialization. The critical pathway to the clinic is complex and advancing towards commercialization for stem cell therapies is challenging. The journal will focus on cutting edge research which contributes to this process. I look forward to working with Rocky Tuan and other editorial board members to ensure the journal meets the needs of the stem cell research community with an emphasis on translation."